911 related articles for article (PubMed ID: 27534978)
21. Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
Tham JLM; Adams H; Paleri S; Wright C; Dimitriou J; Newcomb A; MacIsaac AI; Whitbourn RJ; Palmer SC
Acta Cardiol; 2020 Jun; 75(3):218-225. PubMed ID: 30931804
[No Abstract] [Full Text] [Related]
22. Prosthesis-patient mismatch is an independent predictor of congestive heart failure after transcatheter aortic valve replacement.
Theron A; Lavagna F; Gaubert G; Resseguier N; Porto A; Ferrara J; Jaussaud N; Morera P; Cuisset T; Deharo P; Collart F
Arch Cardiovasc Dis; 2021; 114(6-7):504-514. PubMed ID: 33509746
[TBL] [Abstract][Full Text] [Related]
23. Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
Abdelghani M; de Winter RJ; Miyazaki Y; Modolo R; Tateishi H; Cavalcante R; Sarmento-Leite R; Mangione JA; Abizaid A; Soliman OII; Onuma Y; Lemos PA; Serruys PW; de Brito FS
Catheter Cardiovasc Interv; 2018 Nov; 92(5):945-953. PubMed ID: 29520970
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves.
Kawashima H; Wang R; Mylotte D; Jagielak D; De Marco F; Ielasi A; Onuma Y; den Heijer P; Terkelsen CJ; Wijns W; Serruys PW; Soliman O
Glob Heart; 2021 Mar; 16(1):20. PubMed ID: 33833944
[TBL] [Abstract][Full Text] [Related]
26. Balloon-expandable transcatheter aortic valve implantation with or without pre-dilation - results of a meta-analysis of 3 multicenter registries.
Ashauer JO; Bonaros N; Kofler M; Schymik G; Butter C; Romano M; Bapat V; Strauch J; Schröfel H; Busjahn A; Deutsch C; Bramlage P; Kurucova J; Thoenes M; Baldus S; Rudolph TK
BMC Cardiovasc Disord; 2019 Jul; 19(1):172. PubMed ID: 31324150
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.
Hahn RT; Pibarot P; Leipsic J; Blanke P; Douglas PS; Weissman NJ; Kapadia S; Thourani VH; Herrmann HC; Nazif T; McAndrew T; Webb JG; Leon MB; Kodali S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1710-1718. PubMed ID: 30121276
[TBL] [Abstract][Full Text] [Related]
28. Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
Deuschl F; Schofer N; Seiffert M; Hakmi S; Mizote I; Schaefer A; Schirmer J; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1167-1174. PubMed ID: 28296065
[TBL] [Abstract][Full Text] [Related]
29. The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre- and postinterventional cardiac computed tomography angiography study.
Bekeredjian R; Bodingbauer D; Hofmann NP; Greiner S; Schuetz M; Geis NA; Kauczor HU; Bryant M; Chorianopoulos E; Pleger ST; Mereles D; Katus HA; Korosoglou G
J Invasive Cardiol; 2015 Mar; 27(3):172-80. PubMed ID: 25740972
[TBL] [Abstract][Full Text] [Related]
30. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
31. Device-dependent association between paravalvar aortic regurgitation and outcome after TAVI.
Dworakowski R; Wendler O; Halliday B; Ludman P; DeBelder M; Ray S; Moat N; Kovac J; Spyt T; Trivedi U; Hildick-Smith D; Blackman D; Marlee D; Cunningham D; MacCarthy PA
Heart; 2014 Dec; 100(24):1939-45. PubMed ID: 25053724
[TBL] [Abstract][Full Text] [Related]
32. Sex Disparities in Hemodynamics and Outcomes in Patients Who Underwent Contemporary Transcatheter Aortic Valve Implantation.
Medranda GA; Rogers T; Case BC; Zhang C; Shea C; Satler LF; Ben-Dor I; Waksman R
Am J Cardiol; 2022 Jul; 174():101-106. PubMed ID: 35550824
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.
Zahn R; Gerckens U; Grube E; Linke A; Sievert H; Eggebrecht H; Hambrecht R; Sack S; Hauptmann KE; Richardt G; Figulla HR; Senges J;
Eur Heart J; 2011 Jan; 32(2):198-204. PubMed ID: 20864486
[TBL] [Abstract][Full Text] [Related]
34. Balloon-expandable transaortic transcatheter aortic valve implantation with or without predilation.
Bonaros N; Kofler M; Frank D; Cocchieri R; Jagielak D; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Bapat V; Rein KA; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Romano M
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):915-923. PubMed ID: 29221741
[TBL] [Abstract][Full Text] [Related]
35. Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation.
Abramowitz Y; Jilaihawi H; Chakravarty T; Maeno Y; Kawamori H; Kazuno Y; Mangat G; Rami T; Allison Z; Anderson D; Chan L; Cheng W; Makkar RR
J Invasive Cardiol; 2016 Oct; 28(10):421-426. PubMed ID: 27705892
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Systematic Predilation, Selective Predilation, and Direct Transcatheter Aortic Valve Implantation With the SAPIEN S3 Valve.
Spaziano M; Sawaya F; Chevalier B; Roy A; Neylon A; Garot P; Hovasse T; Benamer H; Romano M; Unterseeh T; Bouvier E; Cormier B; Morice MC; Lefèvre T
Can J Cardiol; 2017 Feb; 33(2):260-268. PubMed ID: 28034581
[TBL] [Abstract][Full Text] [Related]
37. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
[TBL] [Abstract][Full Text] [Related]
38. Evolution of Procedural and Clinical Outcomes After Balloon-Expanding Transcatheter Aortic Valve Implantation In Canada (from the Early Canadian Experience and SOURCE XT Registries).
Puri R; Webb JG; Al Qoofi F; Welsh RC; Brown C; Masson JB; Natarajan MK; Peniston C; Cheema AN; Radhakrishnan S; Généreux P; Thoenes M; Côté M; Rodés-Cabau J
Am J Cardiol; 2018 Aug; 122(3):461-467. PubMed ID: 29980274
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
40. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial.
Vahanian A; Urena M; Walther T; Treede H; Wendler O; Lefèvre T; Spence MS; Redwood S; Kahlert P; Rodes-Cabau J; Leipsic J; Webb J
EuroIntervention; 2016 Jun; 12(2):e235-43. PubMed ID: 27290682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
